166 related articles for article (PubMed ID: 8357013)
1. Oral zinc therapy in the treatment of alpha-mannosidosis.
Wong LT; Vallance H; Savage A; Davidson AG; Applegarth D
Am J Med Genet; 1993 Jun; 46(4):410-4. PubMed ID: 8357013
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy in alpha-mannosidosis guinea-pigs.
Crawley AC; King B; Berg T; Meikle PJ; Hopwood JJ
Mol Genet Metab; 2006; 89(1-2):48-57. PubMed ID: 16807033
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study.
Roces DP; Lüllmann-Rauch R; Peng J; Balducci C; Andersson C; Tollersrud O; Fogh J; Orlacchio A; Beccari T; Saftig P; von Figura K
Hum Mol Genet; 2004 Sep; 13(18):1979-88. PubMed ID: 15269179
[TBL] [Abstract][Full Text] [Related]
4. Successful unrelated bone marrow transplantation in two siblings with alpha-mannosidosis.
Yesilipek AM; Akcan M; Karasu G; Uygun V; Kupesiz A; Hazar V
Pediatr Transplant; 2012 Nov; 16(7):779-82. PubMed ID: 22775975
[TBL] [Abstract][Full Text] [Related]
5. Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice.
Blanz J; Stroobants S; Lüllmann-Rauch R; Morelle W; Lüdemann M; D'Hooge R; Reuterwall H; Michalski JC; Fogh J; Andersson C; Saftig P
Hum Mol Genet; 2008 Nov; 17(22):3437-45. PubMed ID: 18713755
[TBL] [Abstract][Full Text] [Related]
6. Alpha-mannosidosis in the guinea pig: a new animal model for lysosomal storage disorders.
Crawley AC; Jones MZ; Bonning LE; Finnie JW; Hopwood JJ
Pediatr Res; 1999 Nov; 46(5):501-9. PubMed ID: 10541310
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical analysis of two families with type I and type II mannosidosis.
Bennet JK; Dembure PP; Elsas LJ
Am J Med Genet; 1995 Jan; 55(1):21-6. PubMed ID: 7702090
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of human lysosomal alpha-mannosidase in mouse embryonic stem cells.
Robinson AJ; Crawley AC; Hopwood JJ
Mol Genet Metab; 2005 Jul; 85(3):203-12. PubMed ID: 15979032
[TBL] [Abstract][Full Text] [Related]
9. Behavioural characterisation of the alpha-mannosidosis guinea pig.
Robinson AJ; Crawley AC; Auclair D; Weston PF; Hirte C; Hemsley KM; Hopwood JJ
Behav Brain Res; 2008 Jan; 186(2):176-84. PubMed ID: 17889945
[TBL] [Abstract][Full Text] [Related]
10. T-cell-depleted peripheral blood stem cell transplantation for alpha-mannosidosis.
Albert MH; Schuster F; Peters C; Schulze S; Pontz BF; Muntau AC; Röschinger W; Stachel DK; Enders A; Haas RJ; Schmid I
Bone Marrow Transplant; 2003 Aug; 32(4):443-6. PubMed ID: 12900784
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of recombinant human lysosomal alpha-mannosidase.
Berg T; King B; Meikle PJ; Nilssen Ø ; Tollersrud OK; Hopwood JJ
Mol Genet Metab; 2001 May; 73(1):18-29. PubMed ID: 11350179
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation.
Grewal SS; Shapiro EG; Krivit W; Charnas L; Lockman LA; Delaney KA; Davies SM; Wenger DA; Rimell FL; Abel S; Grovas AC; Orchard PJ; Wagner JE; Peters C
J Pediatr; 2004 May; 144(5):569-73. PubMed ID: 15126988
[TBL] [Abstract][Full Text] [Related]
13. Impaired lysosomal trimming of N-linked oligosaccharides leads to hyperglycosylation of native lysosomal proteins in mice with alpha-mannosidosis.
Damme M; Morelle W; Schmidt B; Andersson C; Fogh J; Michalski JC; Lübke T
Mol Cell Biol; 2010 Jan; 30(1):273-83. PubMed ID: 19884343
[TBL] [Abstract][Full Text] [Related]
14. Alpha-mannosidosis and mutational analysis in a Turkish patient.
Olmez A; Nilssen O; Coşkun T; Klenow H
Turk J Pediatr; 2003; 45(1):46-50. PubMed ID: 12718372
[TBL] [Abstract][Full Text] [Related]
15. The Application of HPLC-FLD and NMR in the Monitoring of Therapy Efficacy in Alpha-Mannosidosis.
Krchňák M; Kodríková R; Matulová M; Nemčovič M; Uhliariková I; Katrlík J; Šalingová A; Hlavatá A; Juríčková K; Baráth P; Mucha J; Pakanová Z
Front Biosci (Landmark Ed); 2023 Feb; 28(2):39. PubMed ID: 36866557
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability of mannosidosis type II: report of two Greek siblings.
Michelakakis H; Dimitriou E; Mylona-Karayanni C; Bartsocas CS
Genet Couns; 1992; 3(4):195-9. PubMed ID: 1472354
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis.
Harmatz P; Cattaneo F; Ardigò D; Geraci S; Hennermann JB; Guffon N; Lund A; Hendriksz CJ; Borgwardt L
Mol Genet Metab; 2018 Jun; 124(2):152-160. PubMed ID: 29716835
[TBL] [Abstract][Full Text] [Related]
18. Direct enzyme transfer from lymphocytes corrects a lysosomal storage disease.
Abraham D; Muir H; Olsen I; Winchester B
Biochem Biophys Res Commun; 1985 Jun; 129(2):417-25. PubMed ID: 4015639
[TBL] [Abstract][Full Text] [Related]
19. Ultra-orphan lysosomal storage diseases: A cross-sectional quantitative analysis of the natural history of alpha-mannosidosis.
Zielonka M; Garbade SF; Kölker S; Hoffmann GF; Ries M
J Inherit Metab Dis; 2019 Sep; 42(5):975-983. PubMed ID: 31222755
[TBL] [Abstract][Full Text] [Related]
20. Electron ionization mass spectra of reduced and permethylated urinary oligosaccharides from patients with mannosidosis.
Jardine I; Matsuura F; Sweeley CC
Biomed Mass Spectrom; 1984 Nov; 11(11):562-8. PubMed ID: 6525412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
